Increased infarct size in uremic rats: reduced ischemia tolerance?
In patients with renal failure, myocardial infarction (MI) is more frequent and the rate of death from acute MI is very high. It has been argued that ischemia tolerance of the heart is reduced in uremia, but direct evidence for this hypothesis has not been provided. It was the purpose of this study (1) to ligate the left coronary artery and to measure the nonperfused area (risk area: total infarction plus penumbra) as well as the area of total infarction in subtotally nephrectomized (SNX) rats compared with sham-operated pair-fed control rats and (2) to examine the effects of potential confounders such as BP, sympathetic overactivity, and salt retention. The left coronary artery was ligated for 60 min, followed by reperfusion for 90 min. For visualizing perfused myocardium, lissamine green ink was injected. The nonperfused area (lissamine exclusion) and the area of total infarction (triphenyltetrazolium chloride stain) were assessed in sections of the left ventricle using image analysis. Groups of SNX rats also received: antihypertensive treatment (nadolol plus hydralazine); moxonidine; high salt diet or low salt diet (1.58% versus 0.015%). In surviving animals, the nonperfused area at risk (as the proportion of total left ventricular area), presumably determined by the geometry of vascular supply, was similar in sham-operated and SNX animals (0.38 +/- 0.13 versus 0.45 +/- 0.09; NS). In contrast, the infarcted area, given as a proportion of the nonperfused risk area, was significantly (P < 0.003) higher in SNX (0.68 +/- 0.09) compared with sham-operated (0.51 +/- 0.11) rats and was not altered by any of the above interventions. The finding that a greater proportion of nonperfused myocardium undergoes total necrosis is consistent with the hypothesis of reduced ischemia tolerance of the heart in renal failure. The findings could explain the high rate of death from MI in patients with impaired renal function.
Dikow
Ralf
R
University Hospital of Heidelberg, Bergheimerstrasse 561, 69115 Heidelberg, Germany. ralf.dikow@med.uni-heidelberg.de
Kihm
Lars Philipp
LP
Zeier
Martin
M
Kapitza
Jolanthe
J
Törnig
Johannes
J
Amann
Kerstin
K
Tiefenbacher
Christiane
C
Ritz
Eberhard
E
D000818:Animals; D001835:Body Weight; D003331:Coronary Vessels / Q000473:pathology; D006352:Heart Ventricles / Q000473:pathology; D006830:Hydralazine / Q000494:pharmacology; D007093:Imidazoles / Q000494:pharmacology; D007511:Ischemia; D008297:Male; D009203:Myocardial Infarction / Q000473:pathology*; D017202:Myocardial Ischemia; D009206:Myocardium / Q000473:pathology; D009248:Nadolol / Q000494:pharmacology; D009336:Necrosis; D009392:Nephrectomy; D010477:Perfusion; D051381:Rats; D017207:Rats, Sprague-Dawley; D015424:Reperfusion; D012492:Salts / Q000494:pharmacology; D013997:Time Factors; D014511:Uremia / Q000473:pathology*
D007093:Imidazoles; D012492:Salts; D006830:Hydralazine; D009248:Nadolol; C043482:moxonidine